These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

624 related articles for article (PubMed ID: 33795647)

  • 41. Telomerase therapy attenuates cardiotoxic effects of doxorubicin.
    Chatterjee S; Hofer T; Costa A; Lu D; Batkai S; Gupta SK; Bolesani E; Zweigerdt R; Megias D; Streckfuss-Bömeke K; Brandenberger C; Thum T; Bär C
    Mol Ther; 2021 Apr; 29(4):1395-1410. PubMed ID: 33388418
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The Tumor-Suppressive Human Circular RNA CircITCH Sponges miR-330-5p to Ameliorate Doxorubicin-Induced Cardiotoxicity Through Upregulating SIRT6, Survivin, and SERCA2a.
    Han D; Wang Y; Wang Y; Dai X; Zhou T; Chen J; Tao B; Zhang J; Cao F
    Circ Res; 2020 Jul; 127(4):e108-e125. PubMed ID: 32392088
    [TBL] [Abstract][Full Text] [Related]  

  • 43. HDL protects against doxorubicin-induced cardiotoxicity in a scavenger receptor class B type 1-, PI3K-, and Akt-dependent manner.
    Durham KK; Chathely KM; Mak KC; Momen A; Thomas CT; Zhao YY; MacDonald ME; Curtis JM; Husain M; Trigatti BL
    Am J Physiol Heart Circ Physiol; 2018 Jan; 314(1):H31-H44. PubMed ID: 28986362
    [TBL] [Abstract][Full Text] [Related]  

  • 44. FNDC5 alleviates oxidative stress and cardiomyocyte apoptosis in doxorubicin-induced cardiotoxicity via activating AKT.
    Zhang X; Hu C; Kong CY; Song P; Wu HM; Xu SC; Yuan YP; Deng W; Ma ZG; Tang QZ
    Cell Death Differ; 2020 Feb; 27(2):540-555. PubMed ID: 31209361
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Adiponectin agonist ADP355 ameliorates doxorubicin-induced cardiotoxicity by decreasing cardiomyocyte apoptosis and oxidative stress.
    Zhao D; Xue C; Li J; Feng K; Zeng P; Chen Y; Duan Y; Zhang S; Li X; Han J; Yang X
    Biochem Biophys Res Commun; 2020 Dec; 533(3):304-312. PubMed ID: 32958254
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Nrf2 deficiency exaggerates doxorubicin-induced cardiotoxicity and cardiac dysfunction.
    Li S; Wang W; Niu T; Wang H; Li B; Shao L; Lai Y; Li H; Janicki JS; Wang XL; Tang D; Cui T
    Oxid Med Cell Longev; 2014; 2014():748524. PubMed ID: 24895528
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inhibition of Carbonyl Reductase 1 Safely Improves the Efficacy of Doxorubicin in Breast Cancer Treatment.
    Jo A; Choi TG; Jo YH; Jyothi KR; Nguyen MN; Kim JH; Lim S; Shahid M; Akter S; Lee S; Lee KH; Kim W; Cho H; Lee J; Shokat KM; Yoon KS; Kang I; Ha J; Kim SS
    Antioxid Redox Signal; 2017 Jan; 26(2):70-83. PubMed ID: 27357096
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Baicalin-peptide supramolecular self-assembled nanofibers effectively inhibit ferroptosis and attenuate doxorubicin-induced cardiotoxicity.
    Zeng Y; Liao X; Guo Y; Liu F; Bu F; Zhan J; Zhang J; Cai Y; Shen M
    J Control Release; 2024 Feb; 366():838-848. PubMed ID: 38145663
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The anti-cancer drug doxorubicin induces substantial epigenetic changes in cultured cardiomyocytes.
    Hanf A; Oelze M; Manea A; Li H; Münzel T; Daiber A
    Chem Biol Interact; 2019 Nov; 313():108834. PubMed ID: 31545955
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Protective effects of necrostatin-1 on doxorubicin-induced cardiotoxicity in rat heart.
    Erdogmus Ozgen Z; Erdinc M; Kelle İ; Erdinc L; Nergiz Y
    Hum Exp Toxicol; 2022; 41():9603271211066066. PubMed ID: 35137609
    [No Abstract]   [Full Text] [Related]  

  • 51. RARG S427L attenuates the DNA repair response to doxorubicin in induced pluripotent stem cell-derived cardiomyocytes.
    Huang H; Christidi E; Shafaattalab S; Davis MK; Tibbits GF; Brunham LR
    Stem Cell Reports; 2022 Apr; 17(4):756-765. PubMed ID: 35364012
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Change in TNF-alpha receptor expression is a relevant event in doxorubicin-induced H9c2 cardiomyocyte cell death.
    Chiosi E; Spina A; Sorrentino A; Romano M; Sorvillo L; Senatore G; D'Auria R; Abbruzzese A; Caraglia M; Naviglio S; Illiano G
    J Interferon Cytokine Res; 2007 Jul; 27(7):589-97. PubMed ID: 17651020
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cell death regulation in myocardial toxicity induced by antineoplastic drugs.
    Yu X; Yang Y; Chen T; Wang Y; Guo T; Liu Y; Li H; Yang L
    Front Cell Dev Biol; 2023; 11():1075917. PubMed ID: 36824370
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Klotho attenuated Doxorubicin-induced cardiomyopathy by alleviating Dynamin-related protein 1 - mediated mitochondrial dysfunction.
    Zhuang X; Sun X; Zhou H; Zhang S; Zhong X; Xu X; Guo Y; Xiong Z; Liu M; Lin Y; Zhang M; Liao X
    Mech Ageing Dev; 2021 Apr; 195():111442. PubMed ID: 33539906
    [TBL] [Abstract][Full Text] [Related]  

  • 55. All-trans retinoic acid protects against doxorubicin-induced cardiotoxicity by activating the ERK2 signalling pathway.
    Yang L; Luo C; Chen C; Wang X; Shi W; Liu J
    Br J Pharmacol; 2016 Jan; 173(2):357-71. PubMed ID: 26507774
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Neutrophil extracellular traps mediate cardiomyocyte ferroptosis via the Hippo-Yap pathway to exacerbate doxorubicin-induced cardiotoxicity.
    Zhao P; Li Y; Xu X; Yang H; Li X; Fu S; Guo Z; Zhang J; Li H; Tian J
    Cell Mol Life Sci; 2024 Mar; 81(1):122. PubMed ID: 38456997
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Nicotinamide riboside promotes autolysosome clearance in preventing doxorubicin-induced cardiotoxicity.
    Zheng D; Zhang Y; Zheng M; Cao T; Wang G; Zhang L; Ni R; Brockman J; Zhong H; Fan GC; Peng T
    Clin Sci (Lond); 2019 Jul; 133(13):1505-1521. PubMed ID: 31266854
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Doxorubicin attenuates CHIP-guarded HSF1 nuclear translocation and protein stability to trigger IGF-IIR-dependent cardiomyocyte death.
    Huang CY; Kuo WW; Lo JF; Ho TJ; Pai PY; Chiang SF; Chen PY; Tsai FJ; Tsai CH; Huang CY
    Cell Death Dis; 2016 Nov; 7(11):e2455. PubMed ID: 27809308
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Enhanced-autophagy by exenatide mitigates doxorubicin-induced cardiotoxicity.
    Lee KH; Cho H; Lee S; Woo JS; Cho BH; Kang JH; Jeong YM; Cheng XW; Kim W
    Int J Cardiol; 2017 Apr; 232():40-47. PubMed ID: 28159361
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Rac1 signalling mediates doxorubicin-induced cardiotoxicity through both reactive oxygen species-dependent and -independent pathways.
    Ma J; Wang Y; Zheng D; Wei M; Xu H; Peng T
    Cardiovasc Res; 2013 Jan; 97(1):77-87. PubMed ID: 23027656
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.